2,5-Diphenyloxazole, approx. 99%, for scintillation, 500 g, plastic packaging.

4-(4-(Trifluoromethoxy)phenyl)piperidine hydrochloride, 95.0%, 5g

N-Methyl-2-nitro-4-(trifluoromethyl)aniline, 95.0%, 5g

2-(pyrrolidin-1-yl)propan-1-amine; oxalic acid, 95.0%, 500mg

N-HYDROXY-4-IODOBENZAMIDE, 95%, 250mg

2-Chloro-6-(trifluoromethyl)pyridin-4-amine, 95.0%, 250mg

5-Amino-2-methylisoindolin-1-one, 95.0%, 250mg

3,6,9,12-Tetraoxatetradecane-1,14-diamine, 95.0%, 5g

2-Amino-3-(3-fluoro-4-(trifluoromethyl)phenyl)propanoic acid hydrochloride, 250mg

5-Chloro-2-nitro-4-(trifluoromethyl)aniline, 95.0%, 5g

(3-Methoxypyridin-4-yl)methanamine hydrochloride, 95.0%, 250mg

Ethyl 2-(2-formyl-4,6-dimethoxyphenoxy)acetate, 95.0%, 250mg

n-Butyl phenyl ether, 99.0%, 25ml